Image-guided helical tomotherapy for localized prostate cancer: technique and initial clinical observations.
The purpose of the present study was to implement a technique for daily computed tomography (CT)-based image-guided radiation therapy and to report observations on treatment planning, imaging, and delivery based on the first 2 years of clinical experience. Patients with previously untreated stage T1-T3 biopsy-proven adenocarcinoma of the prostate were considered eligible for treatment with daily CT-guided helical tomotherapy. The prostate was targeted daily using megavoltage CT (MVCT) images that were fused with treatment-planning CT images based on anatomic alignments. All patients were treated at 2 Gy per fraction to 76-78 Gy (mean: 76.7 Gy). As part of this study, 33 prostate patients were planned, imaged, and treated with a total of 1266 CT-guided fractions. The prostate, rectum, bladder, femoral heads, and pubis symphysis were visible in one or more slices for all 1266 MVCT image sets. The typical range of measured prostate displacement relative to a 3-point external laser setup in this study was 2-10 mm [3.4 mm standard deviation (SD)] in the anterior-posterior direction, 2-8 mm (3.7 mm SD) in the lateral direction, and 1-6 mm (2.4 mm SD) in the superior-inferior direction. The obese patients in this study had a substantially larger lateral variation (8.2 mm SD) attributable to mobility of skin marks. The prostate, seminal vesicles, rectum, and bladder anatomy were used to position the patient relative to the desired treatment position without the use of implanted markers. Acute toxicities were within the expected range given the number of patients treated and the dose level.
Ramsey
Chester R
CR
Thompson Cancer Survival Center, Knoxville, Tennessee, U.S.A.|The University of Tennessee, Knoxville, Tennessee, U.S.A.
Scaperoth
Daniel
D
Thompson Cancer Survival Center, Knoxville, Tennessee, U.S.A.
Seibert
Rebecca
R
Thompson Cancer Survival Center, Knoxville, Tennessee, U.S.A.|The University of Tennessee, Knoxville, Tennessee, U.S.A.
Chase
Daniel
D
Thompson Cancer Survival Center, Knoxville, Tennessee, U.S.A.
Byrne
Thomas
T
Thompson Cancer Survival Center, Knoxville, Tennessee, U.S.A.
Mahan
Stephen
S
Thompson Cancer Survival Center, Knoxville, Tennessee, U.S.A.
D000230:Adenocarcinoma / Q000000981:diagnostic imaging* / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D010865:Pilot Projects; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging* / Q000532:radiotherapy*; D011881:Radiotherapy, Computer-Assisted / Q000379:methods*; D020266:Radiotherapy, Conformal / Q000379:methods*; D036542:Tomography, Spiral Computed / Q000379:methods*; D016896:Treatment Outcome
Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):706-13
15936549
Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):391-402
10661346
Radiother Oncol. 1995 Oct;37(1):35-42
8539455
Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1239-46
15913917
Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1218-24
12873664
Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):686-97
12377319
Int J Radiat Oncol Biol Phys. 2002 Nov 15;54(4):1036-46
12419429
Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):876-82
17011460
Med Phys. 1997 Mar;24(3):425-36
9089594
Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):261-8
12023128
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):123-33
16111580
Med Phys. 1999 Jan;26(1):55-64
9949398
Int J Radiat Oncol Biol Phys. 1994 Jul 30;29(5):1119-23
8083081
Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):715-20
9635724
Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):154-63
15850916
Int J Radiat Oncol Biol Phys. 1996 Jan 15;34(2):451-8
8567348
Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):525-33
10348281
Int J Radiat Oncol Biol Phys. 1995 Dec 1;33(5):1311-20
7493856
Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):975-84
16253772
Int J Radiat Oncol Biol Phys. 1996 Jul 15;35(5):1027-34
8751412
Phys Med Biol. 1999 Jul;44(7):1815-41
10442715
Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1602-10
15590192
Med Phys. 1993 Nov-Dec;20(6):1709-19
8309444
Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):647-53
17011443
Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):412-8
15145157
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):141-9
16111582
Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):406-17
15890582
Int J Radiat Oncol Biol Phys. 1997 Jan 1;37(1):3-11
9054871
Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):685-98
11172950
Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):289-302
10925000
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1291-6
16029784
Int J Radiat Oncol Biol Phys. 1995 Dec 1;33(5):1321-9
7493857
Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1225-33
12873665
Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):965-73
15989996
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):933-7
15708277
Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):623-35
15380600
Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1576-83
16125871
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1517-24
16029814
Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):206-14
12007961
Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):988-93
11704322
Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):329-34
15337572
Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):592-605
12243840
Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1024-8
16005575
Phys Med Biol. 2000 Dec;45(12):3545-62
11131183